ClinicalTrials.govpublic full text
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
diffuse large b-cell lymphoma (dlbcl), non-hodgkin lymphomas (nhl), b-cell non-hodgkin lymphomas (b-nhl), diffuse large b-cell lymphoma, odronextamab, anti-cd20 × anti-cd3 bispecific antibody, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 873561
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.